Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa...

por Helen Cox, ProfPhD, Zubeida Salaam-Dreyer, PhD, Galo A Goig, PhD, Mark P Nicol, ProfPhD, Fabrizio Menardo, PhD, Anzaan Dippenaar, PhD, Erika Mohr-Holland, MPH, Johnny Daniels, BA, Patrick G T Cudahy, PhD, Sonia Borrell, PhD, Miriam Reinhard, MD, Anna Doetsch, MSc, Christian Beisel, PhD, Anja Reuter, MD, Jennifer Furin, MD, Sebastien Gagneux, ProfPhD, Robin M Warren, ProfPhD
Publicado 2021